Hints and tips:
...The company needs to launch new products to replace its blockbuster asthma and eczema drug Dupixent, where Sanofi’s exclusive rights run out in the early 2030s....
...Investors had worried about the company’s dependence on its hit eczema and asthma drug Dupixent, which it developed with Regeneron....
...Analysts said the setback raised questions about the strength of Sanofi’s pipeline of drugs and risked leaving it dependent on blockbuster eczema and asthma drug Dupixent....
...Sanofi expects to increase profits in the low double digits this year, helped by its blockbuster eczema and asthma drug Dupixent that is at the heart of chief executive Paul Hudson’s plan to overhaul the...
...It doesn’t help that the CDC website lists “moderate to severe asthma” as one of the primary risk factors for poor coronavirus outcomes — while the American Academy of Allergy Asthma and Immunology says...
...One success was Dupixent, which treats allergic diseases such as eczema and asthma. Sales hit €2.07bn last year, and could reach €10bn annually, Sanofi hopes....
...The drug, which Sanofi has billed as its next blockbuster, can also be used to treat severe asthma....
...GlaxoSmithKline reported a better than expected 14 per cent increase in earnings for the final quarter of 2018, but said competition to its blockbuster Advair asthma drug meant earnings would fall this year...
...Philip Goulder, professor of immunology at the University of Oxford, points out that several critical immune genes are located on the X chromosome — of which women have two copies and men one....
...His own personal and family history of asthma and allergies has meant he has always been fascinated by the immune system....
...But he argued that the company already had a strong franchise in areas beyond oncology, such as immunology and autoimmune diseases....
...The researchers will follow up the infants to see whether there are long-term effects on allergy, especially asthma, at school age....
...Derived from the Greek for “other” and “energy” or “reaction” (”not a happy combination”, sniffed The Lancet), von Pirquet’s coinage brought together familiar symptoms and the new science of immunology....
...A study published in the Journal of Allergy and Clinical Immunology found that the number of children who reported having peanut allergies doubled between 1997 and 2002....
International Edition